Viyash Scientific Q1 FY27 Results (NSE: VIYASH)
Signal: Steady quarter
The read
The standalone quarter shows a modest revenue trajectory at ₹3,536.90 million, up 7.8% YoY but down 5.0% QoQ, with calculated gross margin contracting approximately 100bps as raw-material cost rose to 46.7% of revenue from 40.3%; PAT still grew 20.9% to ₹209.20 million because finance costs fell 76.1%, while the ₹191 million ESOP expense makes the underlying operating margin trend less favorable. Consolidated earnings cannot be assessed because the consolidated results table is absent from the filing extract.
P&L walk
Standalone revenue increased 7.8% YoY to ₹3,536.90 million, while calculated gross margin declined by approximately 100bps as materials and employee costs grew faster than revenue; PAT rose 20.9% to ₹209.20 million, aided by sharply lower finance costs.
Key positives
- Standalone PAT rose 20.9% YoY to ₹209.20 million despite revenue growth of 7.8%, helped by a 76.1% decline in finance costs to ₹14.40 million.
- EPS increased 20.0% YoY to ₹0.48 and broadly tracked PAT, with no material standalone PAT-to-EPS divergence.
- The company plans to subscribe up to ₹400,02,15,648 in AAHL through a rights issue, adjusted against intercompany loans, with the stated objective of strengthening the subsidiary's capital structure and reducing interest burden.
Key concerns
- Calculated gross margin declined approximately 100bps YoY as raw-material cost rose to 46.7% of revenue from 40.3%; the filing does not disclose the cause or evidence of pricing pass-through.
- Employee benefits expense increased 31.3% YoY to ₹706.40 million versus 7.8% revenue growth, including ₹191 million of incremental ESOP expense.
- Standalone revenue declined 5.0% QoQ to ₹3,536.90 million and PAT declined 41.6% QoQ to ₹209.20 million, indicating a sharp sequential slowdown after the prior quarter.
Research and educational content only. Not investment advice.